There's been a lot of talk about a dearth of innovation in the pharma business. But some drugmakers don't lack creativity. In fact, a few of them actually made Forbes' latest list of 100 most innovative companies on the globe.
Two biotechs made the list--Regeneron Pharmaceuticals ($REGN) and Alexion Pharmaceuticals ($ALXN)--but we'll let FierceBiotech explain that. Our concerns are the four pharma companies: Perrigo ($PRGO), Valeant Pharmaceuticals ($VRX), Novo Nordisk ($NVO) and Mylan ($MYL). They're ranked 22nd, 62nd, 70th and 90th, respectively, based on an "Innovation Premium" that measures stock gains based on expectations of new products, services and markets.
Image Courtesy of marin / FreeDigitalPhotos.net
To read the original article: Which are pharma's top 4 innovators? Hint: It's not the big guys - FiercePharma
